These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9093883)

  • 21. Immunosuppressive therapy in renal transplantation.
    Fedric TN
    Crit Care Nurs Clin North Am; 1990 Mar; 2(1):123-31. PubMed ID: 2357308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal long-term immunotherapy protocols.
    Mathew TH
    Transplant Proc; 1999; 31(1-2):1102-3. PubMed ID: 10083492
    [No Abstract]   [Full Text] [Related]  

  • 23. Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantation.
    Golshayan D; Pascual M
    Transpl Immunol; 2008 Nov; 20(1-2):21-8. PubMed ID: 18775494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine improves results in HLA-identical sibling renal transplants.
    Van Buren D; MacDonell R; Johnson HK; Richie R; Ynares C; Helderman JH; Green W; Crowe D
    Transplant Proc; 1994 Oct; 26(5):2514-5. PubMed ID: 7940772
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppression in kidney transplantation in Poland.
    Paczek L; Lao M; Durlik M; Szmidt J; Rowinski W
    Transplant Proc; 2004 Mar; 36(2 Suppl):173S-176S. PubMed ID: 15041331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine monotherapy as primary immunosuppression in renal transplantation--five-year experience.
    Andreu J; Campistol JM; Oppenheimer F; Torregrosa V; Ricart MJ; Vilardell J; Carretero P
    Transplant Proc; 1994 Feb; 26(1):337-40. PubMed ID: 8109006
    [No Abstract]   [Full Text] [Related]  

  • 28. Steroid Withdrawal or Avoidance after Kidney Transplant.
    Wright LS
    Nephrol Nurs J; 2014; 41(6):613-7. PubMed ID: 26287060
    [No Abstract]   [Full Text] [Related]  

  • 29. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
    Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
    Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney transplantation in Kermanshah, Iran: a 5-year experience.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2765-6. PubMed ID: 7482905
    [No Abstract]   [Full Text] [Related]  

  • 32. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
    Cherikh WS; Kauffman HM; McBride MA; Maghirang J; Swinnen LJ; Hanto DW
    Transplantation; 2003 Nov; 76(9):1289-93. PubMed ID: 14627905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 35. [From acute to chronic rejection after kidney transplantation].
    Arns W; Weber M
    Med Klin (Munich); 2002 Oct; 97(10):609-13. PubMed ID: 12386794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract]   [Full Text] [Related]  

  • 37. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
    Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G
    Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
    [No Abstract]   [Full Text] [Related]  

  • 38. [Humoral immunity and kidney transplantation. Possibilities and desensitizing treatment].
    Rowshani AT; Lardy NM; Surachno JS; ten Berge RJ
    Ned Tijdschr Geneeskd; 2009 Mar; 153(13):612-6. PubMed ID: 19408538
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
    Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract]   [Full Text] [Related]  

  • 40. Single center experience with thymoglobulin in renal transplantation.
    Zaltzman JS; Paul LC
    Transplant Proc; 1997 Nov; 29(7A):27S-28S. PubMed ID: 9366924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.